PDCD1 and neoplasm: Since the expression of PD‐L1 on tumor cells severely impairs T cell‐mediated immunosurveillance by binding to PD‐1, we speculated whether zosuquidar could suppress tumor growth in vivo by reducing PD‐L1 expression.